DNMT3A and neuroendocrine neoplasm: DNMT3A protein overexpression, detected with immunohistochemistry, has been previously linked to pejorative prognosis in solid cancers, such as retinoblastoma [83], breast carcinoma [84] or gastroenteropancreatic neuroendocrine tumours [85].